A meta-analysis of palifermin efficacy for the management of oral mucositis in patients with solid tumours and haematological malignancy

Concordance of the WHO, RTOG, and CTCAE v4.0 grading scales for the evaluation of oral mucositis associated with chemoradiation therapy for the treatment of oral and oropharyngeal cancers

(2021) Alessandro Villa et al.   SUPPORTIVE CARE IN CANCER

Topical Esomeprazole Mitigates Radiation-Induced Dermal Inflammation and Fibrosis

(2019) Ngoc Pham et al.   RADIATION RESEARCH

The role of NLRP3 inflammasome activation in radiation damage

(2019) Jinlong Wei et al.   BIOMEDICINE & PHARMACOTHERAPY

Consumption of β-glucans to spice up T cell treatment of tumors: a review

(2018) Priscilla de Graaff et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Acquired Amino Acid Deficiencies: A Focus on Arginine and Glutamine

(2017) Claudia R. Morris et al.   NUTRITION IN CLINICAL PRACTICE

Long-Term Safety Outcomes in Patients with Hematological Malignancies Undergoing Autologous Hematopoietic Stem Cell Transplantation Treated with Palifermin to Prevent Oral Mucositis

(2016) Patrick J. Stiff et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Safety, Pharmacokinetics, and Efficacy of Palifermin in Children and Adolescents with Acute Leukemias Undergoing Myeloablative Therapy and Allogeneic Hematopoietic Stem Cell Transplantation: A Pediatric Blood and Marrow Transplant Consortium Trial

(2016) Joan Morris et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Association of human papillomavirus and p16 status with mucositis and dysphagia for head and neck cancer patients treated with radiotherapy with or without cetuximab: Assessment from a phase 3 registration trial

(2016) James A. Bonner et al.   EUROPEAN JOURNAL OF CANCER

Efficacy and effects of palifermin for the treatment of oral mucositis in patients affected by acute lymphoblastic leukemia

(2015) Alessandra Lucchese et al.   LEUKEMIA & LYMPHOMA

Palifermin for prevention of oral mucositis in allogeneic hematopoietic stem cell transplantation: a single-institution retrospective evaluation

(2015) Diana T. Nguyen et al.   SUPPORTIVE CARE IN CANCER

Pharmacoeconomic Analysis of Palifermin to Prevent Mucositis among Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation

(2014) Ajay K. Nooka et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia

(2014) Kenneth F. Bradstock et al.   BRITISH JOURNAL OF HAEMATOLOGY

Single-Dose Palifermin Prevents Severe Oral Mucositis During Multicycle Chemotherapy in Patients With Cancer

(2013) Saroj Vadhan-Raj   ANNALS OF INTERNAL MEDICINE

Impact of palifermin on intestinal mucositis of HSCT recipients after BEAM

(2013) A H E Herbers et al.   BONE MARROW TRANSPLANTATION

Impact of palifermin on incidence of oral mucositis and healthcare utilization in children undergoing autologous hematopoietic stem cell transplantation for malignant diseases

(2013) Kelly M. Vitale et al.   PEDIATRIC TRANSPLANTATION

In a high-dose melphalan setting, palifermin compared with placebo had no effect on oral mucositis or related patient’s burden

(2012) N Blijlevens et al.   BONE MARROW TRANSPLANTATION

Palifermin is efficacious in recipients of TBI-based but not chemotherapy-based allogeneic hematopoietic stem cell transplants

(2012) J D Goldberg et al.   BONE MARROW TRANSPLANTATION

Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients

(2012) Judith E. Raber-Durlacher et al.   SUPPORTIVE CARE IN CANCER

Systematic review of agents for the management of gastrointestinal mucositis in cancer patients

(2012) Rachel J. Gibson et al.   SUPPORTIVE CARE IN CANCER

Palifermin Reduces Severe Mucositis in Definitive Chemoradiotherapy of Locally Advanced Head and Neck Cancer: A Randomized, Placebo-Controlled Study

(2011) Quynh-Thu Le et al.   JOURNAL OF CLINICAL ONCOLOGY

Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial

(2011) Michael Henke et al.   JOURNAL OF CLINICAL ONCOLOGY

Impact of palifermin on mucosal toxicity in autologous stem cell transplants using busulfan–melphalan conditioning chemotherapy for Hodgkin and non-Hodgkin lymphoma

(2011) Philip Campbell et al.   LEUKEMIA & LYMPHOMA

Use of palifermin for the prevention of high-dose methotrexate-induced oral mucositis

(2008) E. Schmidt et al.   ANNALS OF ONCOLOGY

Palifermin reduces incidence and severity of oral mucositis in allogeneic stem-cell transplant recipients

(2008) S Langner et al.   BONE MARROW TRANSPLANTATION

Gut protection by palifermin during autologous haematopoietic SCT

(2008) J-E Johansson et al.   BONE MARROW TRANSPLANTATION

Keratinocyte growth factor is effective in the prevention of intestinal mucositis in patients with hematological malignancies treated with high-dose chemotherapy and autologous hematopoietic SCT: a video-capsule endoscopy study

(2008) P Tsirigotis et al.   BONE MARROW TRANSPLANTATION

Phase II Study of Palifermin and Concurrent Chemoradiation in Head and Neck Squamous Cell Carcinoma

(2008) David M. Brizel et al.   JOURNAL OF CLINICAL ONCOLOGY